Literature DB >> 15144891

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells.

Bharti Mackness1, David Hine, Yifen Liu, Maria Mastorikou, Mike Mackness.   

Abstract

The upregulation of endothelial cell MCP-1 production by ox-LDL is a major initiating event in atherogenesis. HDL and PON1 retard the oxidation of LDL and therefore may retard endothelial cell MCP-1 production. The endothelial cell line EAhy926 was incubated with ox-LDL in the presence and absence of HDL and PON1 and the production of MCP-1 was measured by ELISA. Human HDL and PON1 significantly inhibited the in vitro oxidation of LDL and completely prevented the ox-LDL induced increase in MCP-1 production by endothelial cells. Ostrich HDL that does not contain PON1 was unable to prevent LDL-oxidation or the production of MCP-1 by endothelial cells. PON1 attenuates the ox-LDL induced MCP-1 production by endothelial cells. This is one, early, mechanism by which PON1 may be anti-atherogenic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15144891     DOI: 10.1016/j.bbrc.2004.04.056

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

Review 1.  Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.

Authors:  K Mahdy Ali; A Wonnerth; K Huber; J Wojta
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  The aryl hydrocarbon receptor is activated by modified low-density lipoprotein.

Authors:  Brian J McMillan; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes.

Authors:  E Rossi; L Della Casa; S Piana; A Iannone
Journal:  Genes Nutr       Date:  2012-05-05       Impact factor: 5.523

Review 4.  High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease.

Authors:  Meliana Riwanto; Ulf Landmesser
Journal:  J Lipid Res       Date:  2013-07-20       Impact factor: 5.922

Review 5.  Evolving concepts of the role of high-density lipoprotein in protection from atherosclerosis.

Authors:  John A Farmer; Joshua Liao
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

6.  Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Authors:  Cheon Ho Park; Su Duy Nguyen; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

Review 7.  Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.

Authors:  Ajibola Monsur Adedayo; Oladipupo Olafiranye; David Smith; Alethea Hill; Ferdinand Zizi; Clinton Brown; Girardin Jean-Louis
Journal:  Sleep Breath       Date:  2012-08-18       Impact factor: 2.816

8.  HDL is the major lipoprotein carrier of plasma F2-isoprostanes.

Authors:  Julie M Proudfoot; Anne E Barden; Wai Mun Loke; Kevin D Croft; Ian B Puddey; Trevor A Mori
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

9.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

10.  Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.

Authors:  M Mastorikou; B Mackness; Y Liu; M Mackness
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.